Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

Nef Holger M.; Wiebe Jens; Kastner Johannes; Mehilli Julinda; Muenzel Thomas; Naber Christoph; Neumann Till; Richardt Gert; Schmermund Axel; Woehrle Jochen; Zahn Ralf; Riemer Thomas; Achenbach Stephan; Hamm Christian W.

首页> 外文期刊>EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology >Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

【24h】

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

机译：冠状动脉疾病患者的everolimus洗脱生物可吸收的支架：德国奥地利吸收登记处的结果（Gabi-R）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: The aim of this study was to analyse the procedural results and midterm safety of everolimus-eluting bioresorbable vascular scaffolds (BVS) used for percutaneous coronary intervention in a large all-comers cohort from the German-Austrian ABSORB RegIstRy (GABI-R).

机译：目的：本研究的目的是分析用于从德国 - 奥地利的德国吸收登记处（Gabi-R）的大型全能队列的经皮冠状动脉介入的经过冠状动脉介入的程序结果和中期安全。

著录项

来源
《EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology》 |2017年第11期|共8页
作者
Nef Holger M.; Wiebe Jens; Kastner Johannes; Mehilli Julinda; Muenzel Thomas; Naber Christoph; Neumann Till; Richardt Gert; Schmermund Axel; Woehrle Jochen; Zahn Ralf; Riemer Thomas; Achenbach Stephan; Hamm Christian W.;
展开▼
作者单位

Univ Giessen Dept Cardiol Med Klin 1 Klin Str 33 D-35392 Giessen Germany;

Deutsch Herzzentrum Munich Munich Germany;

Univ Vienna Sch Med Dept Cardiol Vienna Austria;

Ludwig Maximilian Univ Munich Munich Univ Clin Dept Cardiol Munich Germany;

Johannes Gutenberg Univ Mainz Univ Med Ctr Dept Med 2 Mainz Germany;

Elisabeth Hosp Klin Kardiol &

Angiol Essen Germany;

Univ Essen Gesamthsch Dept Cardiol Essen Germany;

Segeberger Kliniken GmbH Herzzentrum Bad Segeberg Germany;

Cardioangiol Ctr Bethanien Frankfurt Germany;

Univ Ulm Dept Internal Med 2 Ulm Germany;

Herzzentrum Ludwigshafen Abt Kardiol Ludwigshafen Germany;

Inst Herzinfarktforsch Ludwigshafen Germany;

Friedrich Alexander Univ Erlangen Nurnberg Med Klin 2 Erlangen Germany;

Univ Giessen Dept Cardiol Med Klin 1 Klin Str 33 D-35392 Giessen Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词
acute coronary syndrome/non-ST-elevation acute coronary syndrome (ACS/NSTE-ACS); bioresorbable scaffolds; non-ST-elevation myocardial infarction (NSTEMI); stable angina; ST-elevation myocardial infarction (STEMI); stent thrombosis;

机译：急性冠状动脉综合征/非ST-EXPOATION急性冠状动脉综合征（ACS / NSTE-ACS）;生物可见的支架;非ST-EXTATIONY心肌梗死（NSTEMI）;稳定的心绞痛;ST升高心肌梗死（STEMI）;支架血栓形成;

相似文献

外文文献
中文文献
专利

1. Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R) [J] . Nef Holger M., Wiebe Jens, Kastner Johannes, EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology . 2017,第11期

机译：冠状动脉疾病患者的everolimus洗脱生物可吸收的支架：德国奥地利吸收登记处的结果（Gabi-R）
2. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan [J] . Kimura Takeshi, Kozuma Ken, Tanabe Kengo, European Heart Journal: The Journal of the European Society of Cardiology . 2015,第47期

机译：一种随机试验评估威洛米斯洗脱的吸收生物可吸收的支架与冠状动脉疾病患者的Everolimus洗脱金属支架：吸收日本
3. TCT-310 Four-Year Clinical Outcomes From Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial [J] . Runlin Gao Journal of the American College of Cardiology . 2018,第13期

机译：TCT-310 Aptimus洗脱生物可吸收血管支架随机比较的四年临床结果来自吸收中国审判的冠状动脉疾病患者患者血管内洗脱的金属支架
4. Clinical efficacy and safety of native bio-absorbable polymer Rapamycin-eluting stent (Excel stent) for Chinese patients with coronary artery disease [C] . Yanmin Xu, Guangping Li, Li Yin, International Congress on Coronary Artery Disease . 2009

机译：生物可吸收聚合物雷帕霉素洗脱支架（Excel支架）对冠心病患者的临床疗效和安全性
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study [O] . T. M. Hommels, R. S. Hermanides, S. Rasoul, 2019

机译：依维莫司洗脱生物可吸收支架治疗糖尿病患者的冠状动脉疾病：前瞻性ABSORB DM比荷卢研究的中期随访
7. Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study [O] . T. M. Hommels, R. S. Hermanides, S. Rasoul, 2019

机译：Everolimus洗脱的生物可吸收支架，用于治疗糖尿病患者冠状动脉疾病：前瞻性的中期后续的前瞻性DM Benelux研究

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

摘要

著录项

相似文献

相关主题

期刊订阅